Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.74M | 7.76M | 1.38B | 1.14M | 1.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.74M | 7.76M | 1.38B | 1.14M | 1.29M |
| Cost of Revenue | 0.00 | -- | 62.40K | 57.10K | 58.30K |
| Gross Profit | 10.74M | 7.76M | 1.38B | 1.08M | 1.24M |
| SG&A Expenses | 14.31M | 29.90M | 16.80M | 14.51M | 22.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 200.00 | -- | 26.60M | 3.04M | -- |
| Total Operating Expenses | 96.93M | 80.03M | 114.06M | 58.56M | 58.36M |
| Operating Income | -86.19M | -72.26M | 1.27B | -57.42M | -57.06M |
| Income Before Tax | -63.36M | -57.45M | 1.23B | -47.50M | -41.67M |
| Income Tax Expenses | -4.27M | 5.87M | 81.73M | -194.10K | -82.00K |
| Earnings from Continuing Operations | -59.09M | -63.32M | 1.15B | -47.30M | -41.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.09M | -63.32M | 1.15B | -47.30M | -41.59M |
| EBIT | -86.19M | -72.26M | 1.27B | -57.42M | -57.06M |
| EBITDA | -85.80M | -71.13M | 1.27B | -56.58M | -56.68M |
| EPS Basic | -0.84 | -0.90 | 16.29 | -0.67 | -0.59 |
| Normalized Basic EPS | -0.64 | -0.53 | 10.90 | -0.44 | -0.39 |
| EPS Diluted | -0.84 | -0.90 | 16.06 | -0.67 | -0.59 |
| Normalized Diluted EPS | -0.64 | -0.53 | 10.75 | -0.44 | -0.39 |
| Average Basic Shares Outstanding | 70.35M | 70.30M | 70.73M | 70.60M | 70.74M |
| Average Diluted Shares Outstanding | 70.35M | 70.30M | 71.71M | 70.60M | 70.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |